Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Cefpodoxime proxetil

    Product Cefpodoxime proxetil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefpodoxime proxetil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Cefprozil

    Product Cefprozil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefprozil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Product Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.
  • Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Product Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us fo...
  • Ceftiofur sodium sterile & ceftiofur hcl

    Product Ceftiofur sodium sterile & ceftiofur hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftiofur sodium sterile & ceftiofur hcl. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Product Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Cont...
  • Certrorelix acetate injection (0.25 / vial)

    Product Certrorelix acetate injection (0.25 / vial)

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes certrorelix acetate injection (0.25 / vial). It belongs to gynaecology finish formulations products category. Contact us for more information.
  • Cetrizine di hcl

    Product Cetrizine di hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrizine di hcl. It belongs toantiallergic apis category. Contact us for more information.
  • Cetrorelix acetate

    Product Cetrorelix acetate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrorelix acetate. It belongs to infertility apis category. Contact us for more information.
  • Cetuximab

    Product Cetuximab

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetuximab. It belongs to monoclonal antibodies apis category. Contact us for more information.
  • Choline alfoscerate

    Product Choline alfoscerate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate. It belongs to antialzheimer apis category. Contact us for more information.
  • Choline alfoscerate 400 mg soft caps & 250 mg/ml injection

    Product Choline alfoscerate 400 mg soft caps & 250 mg/ml injection

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate 400 mg soft caps & 250 mg/ml injection. It belongs to central nervous system finish formulations products category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)